Neurosciences Research Center, ASRI, Allegheny Campus, Medical College of Pennsylvania and Hahnemann University, 320 East North Avenue, Pittsburgh, PA 15212, USA.
Restor Neurol Neurosci. 1996 Jan 1;9(4):251-6. doi: 10.3233/RNN-1996-9408.
We recently reported that the pineal hormone melatonin protected neuronal cultures from excitotoxicity mediated via kainate-sensitive glutamate receptors and from oxidative stress-induced apoptosis. It has been shown that in rats, a systemic administration of kainate induces apoptotic cell death in various brain regions. In this study, we assayed the extent of brain injury after intraperitoneal (i.p.) administration of 10 mg/kg kainate to rats, using the quantitative TUNEL technique and Nissl staining. We examined the role of melatonin on kainate-induced brain injury by (a) injecting melatonin (4 × 2.5 mg/kg i.p.) prior to and after kainate injection and (b) injecting kainate at the time of low circulating melatonin levels (day/light), and high melatonin levels (night/dark). The extent of kainate-triggered DNA damage and the loss of Nissl staining were lower in animals treated with melatonin, or when kainate was injected at night, i.e. in the presence of high endogenous levels of melatonin. Our results suggest that both the pharmacological use of melatonin and the circadian secretion of endogenous melatonin during the night may reduce the extent of excitotoxic brain injury. Further studies are needed to fully characterize the relevance of our findings for the treatment of progressive neurodegenerative processes which involve excitotoxicity and apoptotic neuronal death.
我们最近报道,松果体激素褪黑素可保护神经元培养物免受通过 kainate 敏感型谷氨酸受体介导的兴奋性毒性和氧化应激诱导的细胞凋亡。已经表明,在大鼠中,全身性给予 kainate 可在各种脑区诱导凋亡性细胞死亡。在这项研究中,我们使用定量 TUNEL 技术和尼氏染色,检测腹腔内(i.p.)给予 10 mg/kg kainate 后大鼠的脑损伤程度。我们通过(a)在给予 kainate 之前和之后注射褪黑素(4×2.5 mg/kg i.p.),以及(b)在低循环褪黑素水平(白天/亮)和高褪黑素水平(夜晚/暗)时给予 kainate,研究褪黑素对 kainate 诱导的脑损伤的作用。用褪黑素处理的动物或在夜间(即内源性褪黑素水平较高时)给予 kainate时,触发的 DNA 损伤和尼氏染色的丧失程度较低。我们的结果表明,褪黑素的药理学应用和夜间内源性褪黑素的节律性分泌都可能减轻兴奋性脑损伤的程度。需要进一步的研究来充分描述我们的发现对涉及兴奋性毒性和凋亡性神经元死亡的进行性神经退行性过程的治疗的相关性。